$5 - MC of around $30bil. That is not how big Pharma work.
They see the potential on the way up and try and get the smaller company at a low price.
I sincerely hope that IVX gets a $ sign in its SP but, being a realist at heart, I can't see an independent $30bil company.
In any case, cancer sufferers will benefit from IVX's success and so will shareholders.
Ann: Complete Regression of TNBC Tumours and Protective Immunity, page-232
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.43M | |||
| Open | High | Low | Value | Volume |
| 13.5¢ | 14.0¢ | 12.5¢ | $74.92K | 574.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 54000 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 61 | 1 |
View Market Depth
| Last trade - 13.01pm 16/06/2025 (20 minute delay) ? |
| IVX (ASX) Chart |